A Study of Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune Thrombocytopenia
Clinical trial NCT04214951 · UNKNOWN
Trial details
- NCT number
- NCT04214951
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-01-01
- Primary completion
- 2022-08-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.